|
|
1.
|
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. MedStar authors:
- Dolman, Sarahfaye
- Kolm, Paul
- Weintraub, William S
Year: 2022
Citation: - JAMA Network Open. 5(2):e2148172, 2022 02 01.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Andrade K, Ballantyne CM, Bellows BK, Bhatt DL, Boden WE, Bress AP, Brinton EA, Derington CG, Dolman S, Jacobson TA, Johnson J, King JB, Kolm P, Miller M, Steg PG, Tajeu GS, Tardif JC, Weintraub WS, Zhang Z
|
|
|
2.
|
An update on pharmacotherapies in diabetic dyslipidemia. [Review] MedStar authors:
Year: 2019
Citation: - Progress in Cardiovascular Diseases. 62(4):334-341, 2019 Jul - Aug.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Bandyopadhyay D, Blumenthal C, Deedwania P, Ghosh RK, Gupta M, Philip K, Tummala R, Ventura H
|
